Trials / Completed
CompletedNCT01753362
Liraglutide In Overweight Patients With Type 1 Diabetes
LIRAGLUTIDE IN OVERWEIGHT PATIENTS WITH TYPE 1 DIABETES
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- University at Buffalo · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effects of liraglutide (a drug used to treat type 2 diabetes) on glucose (sugar) control over the 26 week study period when used in addition to insulin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liraglutide | |
| DRUG | placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2017-12-01
- Completion
- 2018-02-01
- First posted
- 2012-12-20
- Last updated
- 2019-12-17
- Results posted
- 2019-12-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01753362. Inclusion in this directory is not an endorsement.